CoChat

A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery

Open access
Gerhardt, Alana, Voigt, Emily, Archer, Michelle, Reed, Sierra, Larson, Elise, Van Hoeven, Neal, Kramer, Ryan, Fox, Christopher, Casper, Corey · 2022 · Molecular Therapy - Methods & Clinical Development

Published version of a preprint

Cited by 89

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Abstract Current RNA vaccines against SARS-CoV-2 are limited by instability of both the RNA and the lipid nanoparticle delivery system, requiring storage at −20°C or −70°C and compromising universally accessible vaccine distribution. This study demonstrates the thermostability and adaptability of a nanostructured lipid carrier (NLC) RNA vaccine delivery system for use in pandemic preparedness and pandemic response. Liquid NLC is stable at refrigerated temperatures for ≥ 1 year, enabling stockpiling and rapid deployment by point-of-care mixing with any vaccine RNA. Alternatively, NLC complexed with RNA may be readily lyophilized and stored at room temperature for ≥ 8 months or refrigerated temperature for ≥ 21 months. This thermostable RNA vaccine platform could significantly improve distribution of current and future pandemic response vaccines, particularly in low-resource settings. One Sentence Summary An RNA vaccine delivery system stable at room temperature for 8+ months and refrigerated for 21+ months.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omtm.2022.03.009

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 13

  1. Deering, 2014, Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines, Expert Opin. Drug Deliv., 11, 885, 10.1517/17425247.2014.901308 · DOI · Paper page
  2. Zhang, 2019, Advances in mRNA vaccines for infectious diseases, Front Immunol., 10, 594, 10.3389/fimmu.2019.00594 · DOI · Paper page
  3. Kumru, 2014, Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies, Biologicals, 42, 237, 10.1016/j.biologicals.2014.05.007 · DOI · Paper page
  4. Chen, 2013, Desirable attributes of vaccines for deployment in low-resource settings, J. Pharm. Sci., 102, 29, 10.1002/jps.23352 · DOI
  5. Zhao, 2014, Lipid nanoparticles for gene delivery, Adv. Genet., 88, 13, 10.1016/B978-0-12-800148-6.00002-X · DOI · Paper page
  6. Fonte, 2016, Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery, J. Control Release, 225, 75, 10.1016/j.jconrel.2016.01.034 · DOI · Paper page
  7. Alberer, 2017, Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial, Lancet, 390, 1511, 10.1016/S0140-6736(17)31665-3 · DOI · Paper page
  8. Franze, 2018, Lyophilization of liposomal formulations: still necessary, still challenging, Pharmaceutics, 10, 139, 10.3390/pharmaceutics10030139 · DOI · Paper page
  9. Wang, 2019, Lyophilized liposome-based parenteral drug development: reviewing complex product design strategies and current regulatory environments, Adv. Drug Deliv. Rev., 151-152, 56, 10.1016/j.addr.2019.03.003 · DOI
  10. Leung, 2012, Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core, J. Phys. Chem. C Nanomater. Inter., 116, 18440, 10.1021/jp303267y · DOI · Paper page
  11. Chen, 2010, An overview of liposome lyophilization and its future potential, J. Control Release, 142, 299, 10.1016/j.jconrel.2009.10.024 · DOI · Paper page
  12. Kramer, 2018, Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach, Int. J. Nanomedicine, 13, 3689, 10.2147/IJN.S159839 · DOI
  13. Alameh, 2021, Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses, Immunity, 54, 2877, 10.1016/j.immuni.2021.11.001 · DOI · Paper page

Cited by

See all 89

Metadata

Authors
Gerhardt, A., Voigt, E., Archer, M., Reed, S., Larson, E., Van Hoeven, N., Kramer, R., Fox, C., & Casper, C.
Venue
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Published
2022-06
Volume
25
Pages
205-214
ISSN
2329-0501 (ISSN-L)
OpenAlex
W4220709413
Cited by
89
References
29
FWCI
4.90
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery. https://app.cochat.ai/papers/10.1016/j.omtm.2022.03.009
The paper
Gerhardt, A., Voigt, E., Archer, M., Reed, S., Larson, E., Van Hoeven, N., Kramer, R., Fox, C., & Casper, C. (2022). A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery. Molecular Therapy - Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2022.03.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.